Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lancaster, PA
NPI
1962744698
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2112 Harrisburg Pike
Lancaster, PA, 17601
Phone (717) 544-3049
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
1,948 services
Medicare patients, 2024
266
Average age 73
Drug cost, 2024
$955K
2,782 prescriptions
Company payments, 2023
$91.31
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lauren K Brooks was code J0897 (injection, denosumab, 1 mg), 900 times for 14 patients. In total Lauren K Brooks billed 1,948 services in 16 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 900 | 14 | $19.41 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 206 | 160 | $10.31 | $2,124 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 199 | 161 | $12.36 | $2,461 |
| 99214 Office E&M - Established | Facility | 149 | 135 | $72.51 | $11K |
| 99214 Office E&M - Established | Office | 148 | 129 | $74.15 | $11K |
| 99215 Office E&M - Established | Office | 68 | 52 | $114.06 | $7,756 |
| 95251 Test - Miscellaneous | Facility | 66 | 48 | $26.24 | $1,732 |
| 99215 Office E&M - Established | Facility | 65 | 54 | $106.78 | $6,941 |
| 95251 Test - Miscellaneous | Office | 54 | 40 | $25.13 | $1,357 |
| 83036 Blood Count | Office | 20 | 19 | $9.52 | $190 |
| 99205 Office E&M - New | Office | 16 | 16 | $93.26 | $1,492 |
| 96372 Injection Administration | Office | 15 | 14 | $10.64 | $160 |
By year: 2022 $98K for 4,262 services; 2023 $98K for 4,252 services; 2024 $66K for 1,948 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 20 | 19 | $9.52 | $190 |
Medicare prescription drug claims, 2024
In 2024, the drug Lauren K Brooks prescribed most often to Medicare patients was Levothyroxine Sodium, with 542 prescriptions and refills. In total Lauren K Brooks wrote 2,782 Medicare prescriptions that cost $955K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 542 | 1,327 | 138 | $4,902 |
| Synthroid Levothyroxine Sodium | 195 | 485 | 54 | $18K |
| Methimazole Generic | 172 | 437 | 44 | $2,087 |
| Jardiance Empagliflozin | 130 | 262 | 29 | $149K |
| Metformin Hcl Er Metformin Hcl | 126 | 337 | 36 | $1,384 |
| Hydrocortisone Generic | 105 | 171 | 20 | $4,513 |
| Atorvastatin Calcium Generic | 85 | 250 | 31 | $914 |
| Metformin Hcl Generic | 76 | 202 | 23 | $501 |
| Mounjaro Tirzepatide | 73 | 95 | 14 | $98K |
| Ozempic Semaglutide | 71 | 110 | 21 | $101K |
| Alendronate Sodium Generic | 61 | 115 | 15 | $319 |
| Novolog Flexpen Insulin Aspart | 47 | 86 | 19 | $12K |
| Levoxyl Levothyroxine Sodium | 46 | 119 | 16 | $1,930 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 43 | 122 | 15 | $6,057 |
| Testosterone Generic | 42 | 67 | Under 11 | $9,053 |
Brand drugs: 1,118 claims; generic drugs: 1,556 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Lauren K Brooks $91.31 ($91.31 in general payments such as food, travel and fees) from 5 companies. The largest payer was Sanofi-Aventis U.S. LLC with $23.79.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.